Remepy
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
$36MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment
AI security and governance platform purpose-built for enterprise AI agents
AI-first clinical enablement company and developer of remote physical examination technology featuring FDA-cleared medical devices
Pitching Qumra Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room